Top scientists make breakthrough in stem cell research for tendon injuries

Superficial-flexor-tendon-injury-
Superficial-flexor-tendon-injury-

A new form of stem cell treatment could give horses a better chance of recovering from tendon injuries, researchers have suggested.
Stem cell researchers at the Animal Health Trust (AHT) have found positive signs that stem cells originally sourced from embryos coped well in laboratory tests when exposed to inflammation. This is important as inflammation that occurs following an injury can prove damaging to adult tendon cells.
Tendon injuries are a common problem in horses and instead of regenerating healthy tendon tissue, they repair by forming scar tissue which pre-disposes the horse to a high risk of re-injury.
Stem cell treatment has been available for some years, but current treatments use the horse’s own stem cells.
This means they are not available for immediate use as they need to be extracted, cultured and separated from other cells, with the overall timeframe taking several weeks.
Current treatments also work by releasing factors to help tissue repair, rather than rebuilding the tissue itself.
However, the embryonic stem cells grow forever in the lab so can be ready immediately and scientists also believe they work by helping to rebuild the tissue directly, reducing the amount of scar tissue laid down.
The recent work has been funded by the Horserace Betting Levy Board, Racing Foundation, Alice Noakes Memorial Charitable Trust and Beryl Evetts and Robert Lugg Animal Welfare Trust.
Using a laboratory model, they found that adult tendon cells cannot produce “artificial” tendons efficiently when exposed to inflammation.
In contrast, they found that embryonic stem cells that were directed to turn into tendon cells behaved as normal when exposed to inflammation.
Dr Debbie Guest, head of stem cell research at the AHT said: “We were able to demonstrate that these tendon cells express different levels of receptors for inflammatory proteins on their surface.
“This means that these stem cells may provide a useful source of cells for clinical transplantation into the injured tendon as they are unlikely to suffer any negative effects from being placed into an inflamed environment.”
 
 

Facebook
Twitter
LinkedIn
Pinterest

Leave a Reply

Your email address will not be published. Required fields are marked *